Articles From: ACP Re, Ltd. and Tower Group International, Ltd. Announce Receipt of All Regulatory Approvals to Actions Semiconductor Announces Intention to Conduct Dutch Auction Tender Offer for Its Ordinary Shares (including Ordinary Shares represented by American Depositary Shares)


Tower Group International, Ltd.
Sign-up for ACP Re, Ltd. Completes Acquisition of Tower Group International, Ltd. investment picks
SHISHI, China , Oct.
Sign-up for Acquisition Corp. Provides Corporate Update to Shareholders investment picks
2014/7/30
MONTRÉAL, July 30, 2014 /PRNewswire/ - Boralex Inc. ("Boralex" or the "Corporation"), through its subsidiary Boralex Europe S.A., has acquired Calmont 14 MW wind power project in the Midi-Pyrénées region in France .
Sign-up for Acquisition of a 14 MW wind power project in France investment picks
SAN DIEGO and LAS VEGAS , Aug.
Sign-up for Acquisition of Bally Technologies, Inc. by Scientific Games Corporation May Not Be in Shareholders' Best Interests investment picks
FIS ™ (NYSE: FIS), the world’s largest provider of banking and payments technology solutions and a global leader in consulting and outsourcing solutions, has signed a definitive agreement to acquire Brussels-based Clear2Pay.
Sign-up for Acquisition of Clear2Pay Bolsters FIS’ Enterprise Payments Portfolio investment picks
SAN DIEGO and HOUSTON, Aug.
Sign-up for Acquisition of El Paso Pipeline Partners, L.P. by Kinder Morgan, Inc. May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and MATTHEWS, N.C. , July 28, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Family Dollar Stores, Inc. (NYSE: FDO) by Dollar Tree, Inc. (NASDAQ: DLTR) .
Sign-up for Acquisition of Family Dollar Stores, Inc. by Dollar Tree, Inc. May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and JACKSONVILLE, Fla., Aug.
Sign-up for Acquisition of Fortegra Financial Corporation by Tiptree Financial Inc. May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and NEW YORK, July 30, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of GFI Group Inc. (NYSE: GFIG) by CME Group Inc. (NASDAQ: CME) .
Sign-up for Acquisition of GFI Group Inc. by CME Group Inc. May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and BRIGHTON, Mass.
Sign-up for Acquisition of Peoples Federal Bancshares, Inc. by Independent Bank Corp. May Not Be in Shareholders' Best Interests investment picks
Advanced Workflow Solution Will Support Next Decade of Geospatial Data Growth for Service Provider SAN JOSE, Calif.
Sign-up for ACRI-ST Deploys Quantum's StorNext 5 System To Manage And Preserve Critical Satellite Imaging And Remote Sensor Data investment picks
2014/10/6
By Tess Stynes Actavis PLC reached an agreement to acquire specialty pharmaceutical company Durata Therapeutics Inc. in a deal the companies valued at about $675 million, which is expected to strengthen Actavis's business that focuses on infectious diseases.
Sign-up for Actavis agrees to acquire Durata Therapeutics investment picks
- Potential Treatment of Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) in Men and Women Granted Priority Review Status - DUBLIN , Sept.
Sign-up for Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline investment picks
- Potential Treatment For Patients With Complicated Urinary Tract Infections(cUTI) and Complicated Intra-Abdominal Infections (cIAI) - DUBLIN , Sept.
Sign-up for Actavis Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product investment picks
DUBLIN , Sept.
Sign-up for Actavis Confirms Generic Butrans® Patent Challenge investment picks
DUBLIN , Aug.
Sign-up for Actavis Confirms Generic Neupro® Patent Challenge investment picks
DUBLIN , Oct.
Sign-up for Actavis Confirms Generic Quillivant XR® Patent Challenge investment picks
- Second Quarter 2014 GAAP Earnings Per Diluted Share of $0.28 - - 82% Increase in Second Quarter 2014 Adjusted EBITDA to $862 million - DUBLIN , Aug.
Sign-up for Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 investment picks
Actavis PLC (ACT) reportedly is in talks to purchase Salix Pharmaceuticals Ltd.
Sign-up for Actavis reportedly in talks to buy Salix Pharma investment picks
Shares of Actavis Plc (ACT) rose more than 2% in afternoon trade Tuesday, after Bloomberg News reported that the company was approached by Pfizer Inc. (PFE) to discuss a possible deal.
Sign-up for Actavis shares rise on report of Pfizer approach investment picks
- Relamorelin is a Novel Peptide Ghrelin Agonist for Diabetic Gastroparesis - - Actavis Option to Purchase Rhythm Health, Inc. upon Successful Completion of Phase 2b Study - DUBLIN and BOSTON , Oct.
Sign-up for Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin investment picks
- Lead Product DALVANCE™ a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - - Enhances Actavis' Long-term Growth Profile 2015+ - - Experienced Development and Commercial Team Bolsters Actavis' Infectious Disease Expertise - - Leverages Actavis' Hospital Sales and Marketing Capabilities - DUBLIN, Ireland and CHICAGO , Oct.
Sign-up for Actavis to Acquire Durata Therapeutics, Inc. investment picks
DUBLIN , Sept.
Sign-up for Actavis to Host Third Quarter 2014 Earnings Conference Call and Webcast investment picks
Amber Road (NYSE: AMBR), a leading provider of global trade management solutions (GTM) , today announced that the Acteon Group , a leading global integrated subsea services provider, has chosen Amber Road to automate and standardize restricted party screening across all of its worldwide branded services.
Sign-up for Acteon Group Standardizes on Amber Road for Restricted Party Screening investment picks
World-renowned cancer centers and Illumina, Inc. (NASDAQ:ILMN) today announced the formation of the Actionable Genome Consortium (AGC), an effort to recommend openly published standards for the widespread use of next-generation sequencing to guide decision-making in clinical oncology.
Sign-up for Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions investment picks
ZHUHAI, China , Sept.
Sign-up for Actions Semiconductor Announces Final Results of its Tender Offer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ACP Re, Ltd. and Tower Group International, Ltd. Announce Receipt of All Regulatory Approvals to Actions Semiconductor Announces Intention to Conduct Dutch Auction Tender Offer for Its Ordinary Shares (including Ordinary Shares represented by American Depositary Shares)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices